Company: TIPT
Filing Date: 2025-10-17
Form Type: PREM14A
Source: 0001140361-25-038514
Chunk: 151

Company: TIPTREE INC.
Filing Date: 2025-10-17
Form: PREM14A
Chunk 151
---
 concept) to do business as a foreign corporation, partnership, limited liability company or other legal entity in each jurisdiction in which the nature of its business, or the ownership, leasing or operation of its properties or assets, makes such qualification necessary, except where the failure to be so organized, validly existing, in good standing, qualified or licensed or have such power and authority would not reasonably be expected to have a Material Adverse Effect; |

| • | true and complete copies of the organizational documents of each Group Company, as amended as of the date of the Merger Agreement, having been made available to Purchaser, and such organizational documents being in full force and effect as of the date of the Merger Agreement; |

| • | Fortegra’s corporate power and authority execute and deliver the Merger Agreement and each other transaction document to which it is or will be as of the closing a party, to perform its obligations thereunder and to consummate the transactions contemplated thereby and that the Merger Agreement constitutes a valid and binding obligation of Fortegra; |

77

TABLE OF CONTENTS

equity/stockholders’ equity of Fortegra and its Subsidiaries for the six-month period then ended, (iii) the books and records of the Group Companies, (iv) audited annual statutory statements of each insurance Subsidiary, as of and for the year ended December 31, 2024, and as of and for the quarter ended June 30, 2025, (v) accounts or notes receivable held by the Group Companies, (vi) accounts payable of the Group Companies, (vii) certain indebtedness, (viii) material liens against the assets of the Group Companies or the equity interests of the Group Companies and (ix) since December 31, 2024, the absence of any significant deficiencies or material weaknesses in the design or operation of Fortegra’s internal controls over financial reporting, which could be reasonably expected to materially and adversely affect Fortegra’s ability to accurately report financial information;

| • | Fortegra’s authorized and outstanding shares of capital stock and warrants to purchase Fortegra shares; |

| • | Fortegra shares, and each issued and outstanding share of capital stock or other equity interest of each Subsidiary, having been duly authorized and validly issued, fully paid and nonassessable and having not been issued in violation of, and not being subject to, any preemptive or subscription rights or rights of first refusal; |

| • | a true and